Immediate Impact
2 by Nobel laureates 4 from Science/Nature 58 standout
Citing Papers
Rheumatoid arthritis
2023 Standout
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
2023 Standout
Works of Rahul Patel being referenced
Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Rahul Patel | 220 | 106 | 47 | 204 | 108 | 11 | 515 | |
| T Leizer | 180 | 115 | 28 | 170 | 92 | 15 | 534 | |
| Wilfried Barth | 204 | 156 | 29 | 188 | 64 | 19 | 640 | |
| Markus Zeisbrich | 278 | 144 | 52 | 131 | 129 | 16 | 626 | |
| Jeff Faint | 164 | 129 | 34 | 197 | 106 | 11 | 571 | |
| Jean‐Frédéric Boyer | 176 | 109 | 37 | 317 | 53 | 15 | 541 | |
| Oliver Winter | 359 | 96 | 43 | 65 | 159 | 9 | 562 | |
| R I Fox | 189 | 95 | 24 | 128 | 75 | 8 | 509 | |
| N. T. CHEUNG | 186 | 98 | 33 | 288 | 143 | 9 | 568 | |
| Xiangli Xiao | 170 | 164 | 55 | 211 | 71 | 11 | 497 | |
| Susan L. Cuvelier | 188 | 114 | 50 | 133 | 74 | 14 | 552 |
All Works
Login with ORCID to disown or claim papers
Loading papers...